The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(Benzo[d][1,3]dioxol-5-yl)-3-(4-hydroxybutyl)-3,5-dihydro-9H-imidazo[1,2-a]purin-9-one ID: ALA4531506
PubChem CID: 155546542
Max Phase: Preclinical
Molecular Formula: C18H17N5O4
Molecular Weight: 367.37
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=c1c2ncn(CCCCO)c2nc2[nH]c(-c3ccc4c(c3)OCO4)cn12
Standard InChI: InChI=1S/C18H17N5O4/c24-6-2-1-5-22-9-19-15-16(22)21-18-20-12(8-23(18)17(15)25)11-3-4-13-14(7-11)27-10-26-13/h3-4,7-9,24H,1-2,5-6,10H2,(H,20,21)
Standard InChI Key: XDJPONKVTLGALL-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
20.8193 -4.4462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8111 -3.6249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1012 -4.8590 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5952 -3.3649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.6035 -4.6980 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1012 -3.2122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0822 -4.0253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5952 -5.5193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1012 -2.3950 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.3010 -5.9279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0150 -5.5317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4348 -5.5441 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.7249 -5.9403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3913 -4.4421 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3868 -3.6250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.6082 -3.3767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1315 -4.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6155 -4.6988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9074 -4.7448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3143 -4.0403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9070 -3.3342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0884 -3.3370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0969 -4.7460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6848 -4.0445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8903 -4.2196 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8113 -5.0294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5570 -5.3546 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 1 1 0
4 2 1 0
5 1 1 0
6 2 1 0
14 3 2 0
7 5 1 0
8 5 1 0
9 6 2 0
10 8 1 0
11 10 1 0
12 13 1 0
13 11 1 0
7 4 2 0
15 6 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 1 0
23 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 24 2 0
20 17 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.37Molecular Weight (Monoisotopic): 367.1281AlogP: 1.54#Rotatable Bonds: 5Polar Surface Area: 106.67Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.11CX Basic pKa: 1.90CX LogP: 0.57CX LogD: 0.57Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.52Np Likeness Score: -0.47
References 1. Mohammed AF, Andrei G, Hayallah AM, Abdel-Moty SG, Snoeck R, Simons C.. (2019) Synthesis and anti-HSV activity of tricyclic penciclovir and hydroxybutylguanine derivatives., 27 (6): [PMID:30738653 ] [10.1016/j.bmc.2019.02.005 ]